[en] The coronavirus disease 2019 (COVID-19) can be associated with a wide variety of neurological manifestations. Some of these manifestations might result from the ongoing systemic inflammatory state, but the pathophysiology of specific neurologic involvement is still unclear. In this article, we report a patient who developed an isolated cerebellar syndrome 9 weeks after an episode of COVID-19. The reverse-transcriptase polymerase chain reaction (RT-PCR) for SARS-CoV-2 was positive on cerebrospinal fluid (CSF). A post-infectious-autoimmune-cerebellitis following COVID-19 was suspected, and the patient was treated with corticosteroids, leading to a complete recovery within a few weeks. We review the other cases of COVID-19-associated cerebellar syndrome reported so far and discuss the potential pathophysiological mechanisms underlying this neurologic manifestation.
Disciplines :
Neurology
Author, co-author :
Plumacker, Florence ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Lambert, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Maquet, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
Language :
English
Title :
Immune-mediated cerebellitis following SARS-CoV-2 infection-a case report and review of the literature.
Publication date :
August 2023
Journal title :
Journal of Neurovirology
ISSN :
1355-0284
eISSN :
1538-2443
Publisher :
Springer Science and Business Media Deutschland GmbH, United States
Abboud H, Abboud FZ, Kharbouch H, Arkha Y, el Abbadi N, el Ouahabi A (2020) COVID-19 and SARS-Cov-2 infection: pathophysiology and clinical effects on the nervous system. World Neurosurg 140:49–53. 10.1016/j.wneu.2020.05.193 DOI: 10.1016/j.wneu.2020.05.193
Bougakov D, Podell K, Goldberg E (2021) Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol 58:564–575. 10.1007/s12035-020-02152-5 DOI: 10.1007/s12035-020-02152-5
Harapan BN, Yoo HJ (2021) Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol 268(9):3059–3071. 10.1007/s00415-021-10406-y DOI: 10.1007/s00415-021-10406-y
Jafari Khaljiri H, Jamalkhah M, Amini Harandi A, Pakdaman H, Moradi M, Mowla A (2021) Comprehensive review on neuro-COVID-19 pathophysiology and clinical consequences. Neurotox Res 39(5):1613–1629. 10.1007/s12640-021-00389-z DOI: 10.1007/s12640-021-00389-z
Jha NK, Ojha S, Jha SK et al (2021) Evidence of Coronavirus (CoV) Pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J Mol Neurosci 71(11):2192–2209. 10.1007/s12031-020-01767-6 DOI: 10.1007/s12031-020-01767-6
Koralnik IJ, Tyler KL (2020) COVID-19: a global threat to the nervous system. Ann Neurol 88(1):1–11. 10.1002/ana.25807 DOI: 10.1002/ana.25807
Niazkar HR, Zibaee B, Nasimi A, Bahri N (2020) The neurological manifestations of COVID-19: a review article. Neurol Sci 41(7):1667–1671. 10.1007/s10072-020-04486-3 DOI: 10.1007/s10072-020-04486-3
Payus AO, Jeffree MS, Ohn MH et al (2022) Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci 43(3):1533–1547. 10.1007/s10072-021-05785-z DOI: 10.1007/s10072-021-05785-z
Povlow A, Auerbach AJ (2021) Acute cerebellar ataxia in COVID-19 infection: a case report. J Emerg Med 60(1):73–76. 10.1016/j.jemermed.2020.10.010 DOI: 10.1016/j.jemermed.2020.10.010
Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V (2021) Viral infections and systemic lupus erythematosus: new players in an old story. Viruses 13(2):277. 10.3390/v13020277 DOI: 10.3390/v13020277
Xu Y, Zhuang Y, Kang L (2021) A review of neurological involvement in patients with SARS-CoV-2 infection. Med Sci Monit 27:e932962. 10.12659/MSM.932962 DOI: 10.12659/MSM.932962
